TheraRadar
Clinical-Stage Companies / LG Life Sciences

LG Life Sciences

Pre-Approval PRO BETA

Inactive Company

No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 10/17/2016

54
Total Trials
17
Phase 3
5
Phase 2
0
Recruiting
370
Score

Pipeline by Phase

Phase 3
17
Phase 2
5
Phase 1
25

Therapeutic Focus

Healthy Type 2 Diabetes Mellitus Growth Hormone Deficiency Type 2 Diabetes Hyperlipidemia

Clinical Trials (54)

NCT02746380 Phase 3 COMPLETED

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Started: 4/13/2016

NCT02204163 Phase 3 COMPLETED

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Started: 6/1/2014

NCT02715908 Phase 3 COMPLETED

A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Started: 4/1/2016

NCT02831361 Phase 3 COMPLETED

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Started: 10/17/2016

NCT02126358 Phase 3 COMPLETED

Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Started: 5/1/2014

NCT01990469 Phase 3 COMPLETED

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

Started: 1/1/2014

NCT01968044 Phase 3 COMPLETED

A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)

Started: 10/1/2013

NCT01810900 Phase 3 TERMINATED

To Assess the Anti-adhesive Effect and Safety of Protescal

Started: 9/1/2012

NCT02122601 Phase 3 COMPLETED

A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

Started: 4/1/2014

NCT01787396 Phase 3 COMPLETED

Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

Started: 4/1/2013

NCT01918332 Phase 3 COMPLETED

Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

Started: 4/1/2012

NCT01928628 Phase 3 COMPLETED

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

Started: 5/1/2012

NCT01896739 Phase 3 COMPLETED

A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

Started: 8/1/2009

NCT01510535 Phase 3 COMPLETED

Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

Started: 12/1/2011

NCT01601990 Phase 3 COMPLETED

Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes

Started: 12/1/2009

NCT01602003 Phase 3 COMPLETED

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Started: 12/1/2009

NCT01251133 Phase 3 COMPLETED

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Started: 7/1/2008

NCT02070471 Phase 2 COMPLETED

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

Started: 1/1/2014

NCT02042170 Phase 2 COMPLETED

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

Started: 2/1/2014

NCT01624571 Phase 2 COMPLETED

Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

Started: 3/1/2012

NCT01026610 Phase 2 COMPLETED

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Started: 8/1/2009

NCT01122251 Phase 2 COMPLETED

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Started: 12/1/2009

NCT01526577 Phase 1 COMPLETED

Study of LC23-1306 in Healthy Male Subjects

Started: 3/1/2012

NCT02892812 Phase 1 COMPLETED

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Started: 9/1/2016

NCT02426151 Phase 1 COMPLETED

Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects

Started: 4/1/2015

NCT02206867 Phase 1 COMPLETED

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

Started: 8/1/2014

NCT02446353 Phase 1 COMPLETED

Pharmacokinetics and Safety Study of Apetrol ES

Started: 4/1/2010

NCT01662674 Phase 1 COMPLETED

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

Started: 10/1/2012

NCT01595880 Phase 1 COMPLETED

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Started: 12/1/2014

NCT01725620 Phase 1 COMPLETED

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Started: 11/1/2012

NCT01825850 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Started: 6/1/2013

NCT02004587 Phase 1 COMPLETED

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Started: 9/1/2013

NCT02056600 Phase 1 COMPLETED

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

Started: 3/1/2014

NCT01737424 Phase 1 COMPLETED

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

Started: 12/1/2012

NCT01747083 Phase 1 COMPLETED

Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

Started: 1/1/2013

NCT01823133 Phase 1 COMPLETED

Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin

Started: 4/1/2013

NCT01918709 Phase 1 COMPLETED

Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

Started: 9/1/2011

NCT01918358 Phase 1 COMPLETED

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Started: 12/1/2012

NCT01361646 Phase 1 COMPLETED

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Started: 6/1/2011

NCT01768455 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

Started: 2/1/2013

NCT01342055 Phase 1 COMPLETED

Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers

Started: 3/1/2011

NCT01603238 Phase 1 COMPLETED

Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

Started: 5/1/2011

NCT01426399 Phase 1 COMPLETED

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

Started: 8/1/2011

NCT01427868 Phase 1 COMPLETED

Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

Started: 9/1/2010

NCT01426906 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

Started: 1/1/2011

NCT01145950 Phase 1 COMPLETED

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®

Started: 6/1/2010

NCT01001013 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

Started: 2/1/2009

NCT03051087 Phase 4 COMPLETED

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

Started: 10/1/2016

NCT03015909 Phase 4 COMPLETED

Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Started: 8/11/2016

NCT02458768 Phase 4 COMPLETED

Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

Started: 7/1/2013

NCT01890629 Phase 4 COMPLETED

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

Started: 5/1/2013

NCT01659775 Phase 4 COMPLETED

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Started: 8/1/2011

NCT01605331 Phase 4 COMPLETED

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Started: 12/1/2009

NCT01578304 Phase 4 COMPLETED

Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

Started: 12/1/2010

Drug Candidates

LBAL Humira® Ganirelix acetate Eutropin Genotropin Somatropin LC23-1306 placebo Ticagrelor LBEC0101
Activity Status: Inactive
Last Trial Started: 10/17/2016
Last Trial Ended: 4/1/2018
Trials (12 months): 0
Completed Trials: 53
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.